Nevertheless, when comparing early passages between IFNγ‐24 h and IFNγ‐C conditions (Fig. 2S), IDO1 fluorescence intensity is higher in IFNγ‐C treated AD-MCs. The gene discussed is IDO1; the disease is Alzheimer disease.